Deka Biosciences Funding: $40M Raised, Series B (2023)
Deka Biosciences is based in Germantown. It has raised $40M in total funding. Latest round: Series B.
Deka Biosciences funding overview
Deka Biosciences is based in Germantown. Deka Biosciences has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Deka Biosciences runs through 2023; nothing later has been disclosed. Investors on record include MPM Capital, John Mumm, Alexandria Venture Investments, Amana Investments, Atem Capital, Leaps BY Bayer and 2 others. 8 distinct backers are named across the disclosed rounds.
Deka Biosciences at a glance
Total raised
$40M
Latest round
Series B
Latest round date
September 2023
Headquarters
Germantown
Notable investors
MPM Capital, John Mumm, Alexandria Venture Investments, Amana Investments, Atem Capital, Leaps BY Bayer, O BIO, Plains Ventures
Frequently asked about Deka Biosciences funding
How much has Deka Biosciences raised?
Deka Biosciences has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Deka Biosciences?
MPM Capital, John Mumm, Alexandria Venture Investments, Amana Investments, Atem Capital, Leaps BY Bayer are named among the investors backing Deka Biosciences.
What was the latest Deka Biosciences funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is Deka Biosciences based?
Deka Biosciences is based in Germantown.
When did Deka Biosciences last raise?
The last disclosed Deka Biosciences round closed in September 2023 at Series B.
Totals shown for Deka Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Germantown and the investors behind them below.
